Get the NVAX Research Report and
Also Receive Our Top Trades for 2017!

Novavax, Inc.

On July 17, 2017, Novavax, Inc. announced it will host a conference call and webcast on Monday, July 24, 2017, at 4:30 p.m. ET. Novavax anticipates receiving results and announcing topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults (60 years of age and older). In addition, management will provide an update on its prior Phase 2 and Phase 3 clinical trials in older adults and well as its RSV Phase 3 clinical trial for infants via maternal immunizatio … (See Research Report)
Download Research Report
on NVAX Now